Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
Understanding tumour growth variability in breast cancer xenograft models identifies PARP inhibition resistance biomarkers
D. Voulgarelis
J. V. Forment
A. Herencia Ropero
D. Polychronopoulos
J. Cohen-Setton
A. Bender
V. Serra
M. J. O’Connor
J. W. T. Yates
K. C. Bulusu
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1038/s41698-024-00702-x
Nov 18, 2024
Version published to 10.21203/rs.3.rs-3893834/v1 on Research Square
Feb 13, 2024
Related articles
The Underlying Mechanisms and Emerging Strategies to Overcome Resistance in Breast Cancer
This article has 4 authors:
Krishnaswamy Kannan
Alagarsamy Srinivasan
Aarthi Kannan
Nawab Ali
Organoid-evaluable clinical biomarkers predict drug responses and guide new breast cancer therapies
This article has 18 authors:
Tam Binh V. Bui
Denise M. Wolf
Michael C. Bruck
Kaitlin Moore
Jessica Lien
Sarah D.W. Choi
Shruti Warhadpande
Amirabbas Parizadeh
Deborah Dillon
Beth Overmoyer
Filipa Lynce
I-SPY 2 Investigators
Isaac J. Nijman
Boudewijn M.T. Burgering
Isaac S. Harris
Laura J. Esserman
Laura J. van ‘t Veer
Jennifer M. Rosenbluth
Comprehensive analysis of metabolic reprogramming-related gene signaturesmetabolic reprogramming related gene signature for predicting ovarian cancer prognosis, immune landscape, and potential treatment options
This article has 10 authors:
Rendong Han
Enhui Guo
Zhen Li
Huansheng Zhou
Bei Liu
Yan Wang
Xiaomei Hou
FuMin Zheng
Yanan Xu
Jianhong Yu
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up